CRIS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Curis Inc (CRIS) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. While the stock shows minor positive momentum in the short term, its financial performance and lack of significant catalysts make it a hold rather than a buy.
The MACD is positive and expanding, indicating bullish momentum. The RSI is in the neutral zone at 71.305, and moving averages are converging, showing no clear trend. Key resistance levels are at 1.075 and 1.143, with support at 0.856 and 0.788. The stock is trading slightly above its pivot point, suggesting mild upward momentum.
The MACD indicates bullish momentum, and the stock has a 7.92% chance of increasing in the next month. Additionally, the stock price has shown a slight increase in both regular and post-market trading.
The company's financials are weak, with declining net income (-23.41% YoY), EPS (-71.18% YoY), and gross margin (-31.34% YoY). There are no significant hedge fund or insider trading trends, no recent news, and no recent congress trading data. Analyst ratings suggest mixed sentiment, with some downgrades in price targets.
In Q3 2025, revenue increased by 8.36% YoY to $3.176M, but net income dropped to -$7.729M (-23.41% YoY), EPS fell to -0.49 (-71.18% YoY), and gross margin declined to 71.66% (-31.34% YoY). The company is struggling with profitability and efficiency.
Analyst sentiment is mixed. Recent ratings include a Hold from Canaccord with a $30 price target, a Buy from BofA with a lowered target of $35, and an Outperform from Evercore ISI with a lowered target of $38. Analysts highlight potential recovery in 2026 but note current headwinds and valuation concerns.
